Biosense Webster, Inc.   Report issue

For profit Phase 3 Phase 4
Founded: Diamond Bar CA United States (1970)
Status: Acquired by Johnson and Johnson (1997)

Organization Overview

First Clinical Trial
2003
NCT00540787
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Biosense Webster, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 4)

Coronary Artery Disease (Phase 3)

Coronary Disease (Phase 3)

Ischemia (Phase 4)

Myocardial Ischemia (Phase 3)

Tachycardia (Phase 4)

Tachycardia, Ventricular (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 13